CHWY

In the closing of the recent trading day, Chewy (CHWY) stood at $22.13, denoting a -1.29% move from the preceding trading day.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Chewy (CHWY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Recently, Zacks.com users have been paying close attention to Chewy (CHWY). This makes it worthwhile to examine what the stock has in store.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

CHWY is expanding its healthcare platform through Vet Care and Modern Animal to drive customer growth and long-term profitability.

Chewy remains a Strong Buy, with valuation implying a high margin of safety even under conservative assumptions and challenging macro conditions. Q1 delivered 7.7% YoY net sales growth, $71M FCF, record profitability, and nearly 200,000 net customer additions despite consumer headwinds. CHWY's guidance reflects macro pressure: net sales are expected at $13.40–$13.55B and Adj. EBITDA margin at 6.6–6.8%, but long-term potential remains intact.

Chewy is upgraded from Hold to Buy after a 40% stock decline and earnings multiple compression. CHWY's fundamentals have improved, with consistent top and bottom-line growth despite occasional estimate misses. The pet products market remains high-growth, supporting sustained demand and CHWY's upward business trajectory.